:

Does Denosumab Affect Fracture Healing? Understanding the Mechanism and Evidence

While early concerns existed that antiresorptive drugs could inhibit bone repair, clinical evidence, including findings from the pivotal FREEDOM trial, indicates that denosumab does not delay fracture healing. However, its mechanism of action profoundly affects the bone remodeling phase, a critical step in the long-term strength of a healed fracture.